WebPrevious reports show increased incidence of venous thromboembolism [VTE, deep-vein thrombosis (DVT) and pulmonary embolus (PE)] in sickle cell disease (SCD) patients. The incidence, time course, and risk factors for VTE recurrence have been less well described. We determined the cumulative incidenc … WebDec 2, 2024 · To assess the clinical and laboratory predictors of venous thromboembolism (VTE) in patients with sickle cell anaemia (SCA) and its relationship to morbidity and mortality. Methods This retrospective case–control study analysed data from patients with SCA that experienced VTE compared with matched control patients with SCA but no …
The molecular basis for the prothrombotic state in sickle cell …
WebMar 30, 2024 · Sickle cell disease (SCD) is an inherited red blood cell (RBC) disorder resulting from a GAG→GTG substitution (glutamic acid→valine) in the sixth codon of the β-globin subunit of human adult hemoglobin. The resultant variant hemoglobin, Hb S, polymerizes upon deoxygenation, leading to distortion of the RBC shape and rheologic … WebSickle cell disease (SCD) is an inherited gene defect that causes hemoglobin to clump and deform red blood cells, leading to anemia, hemolysis, and vascular occlusions that affect … china snow beer
Sickle cell disease and venous thromboembolism: what the ...
WebThe incidence of venous thromboembolism (VTE; defined as deep vein thrombosis [DVT] or pulmonary embolism [PE]) in adults with sickle cell disease (SCD) is high, with up to 12% of patients experiencing an event before the age of 40 years. VTE recurrence … WebMar 14, 2024 · Black individuals with sickle cell trait (SCT) have an increased risk of developing end-stage renal disease (ESRD), according to new research. The study indicates that having SCT actually doubles the risk of ESRD. And the trait confers a similar degree of risk as APOL1 gene variants, which are WebThe use of a direct oral anticoagulant (DOAC) is not recommended for VTE in patients with sickle cell disease because those patients were not included in the clinical studies. We aimed to study the safety of using DOACs in a prospective cohort of patients with sickle cell disease and VTE. china snowboard jackets clearance